Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA terminal phosphate cyclase-like 1 pseudogene (None)
- Target
- None
- Molecular classification
- Pseudogene, Other (noncoding, defective gene copy)
01
Overview
The RNA terminal phosphate cyclase-like 1 pseudogene (ENSG00000265713, LOC100421100) is a non-protein-coding region of the human genome that closely resembles the sequence of the functional RCL1 gene, which is a nucleolar protein involved in pre-rRNA processing. As a pseudogene, this locus results from the duplication or retrotransposition of RCL1 but has accumulated mutations or structural variants that prevent expression of an active protein product. By standard definition, pseudogenes such as this are genetic relics and have no canonical biochemical function within cells. Rarely, some pseudogenes may influence other genes via RNA-based regulatory mechanisms, but there is no evidence for this in the case of ENSG00000265713. It is not a receptor, enzyme, transporter, or otherwise considered a viable drug target in biomedical research or pharmacology.
- Other names
- LOC100421100ENSG00000265713RNA terminal phosphate cyclase-like 1 (RCL1) pseudogene
02
Mechanism of action
None (no mechanism of drug action because it is not a protein target and is nonfunctional)
03
Biological functions
Other (pseudogenes generally lack protein-coding function, although some pseudogenes may exert regulatory effects as noncoding RNAs)
04
Disease associations
Other (no established direct disease role; while some pseudogenes are implicated through regulatory RNAs or as biomarkers, there is no evidence for disease association specific to this locus)
05
Safety considerations
None (no relevant safety/tolerability concerns because it is not a therapeutic target)
Beyond the preview
Go deeper on RNA terminal phosphate cyclase-like 1 pseudogene (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA terminal phosphate cyclase-like 1 pseudogene (None).